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PURPOSE. To evaluate in different types of glaucoma frequency of family history of glaucoma
(FHG), age at diagnosis, glaucoma risk in relatives, and acceptance rate of genetic glaucoma
tests. To assess stage of visual field loss (VFL) in relation to FHG.
METHODS. Using standardized questions whether an ophthalmologist had found or excluded
glaucoma or ocular hypertension (OH), 2170 patients with glaucoma or OH interviewed all
their first and second degree relatives. One thousand three hundred thirty-eight patients had
POAG, 233 primary angle closure glaucoma (PACG), 148 OH, 153 normal tension glaucoma
(NTG), 50 pigmentary glaucoma (PG), and 66 pseudoexfoliation glaucoma (PEX).
RESULTS. Frequency of FHG was 40% in POAG, without significant differences compared with
NTG (P ¼ 0.08), OH (P ¼ 0.5), PACG (P ¼ 0.4), and PG (P ¼ 0.6). There were significant
differences in age at diagnosis between the glaucomas (smallest between group P < 0.0001).
Patients with FHG were significantly younger at diagnosis than patients without FHG in all
types of glaucoma (all P values  0.03), except NTG and PEX. Patients’ siblings and mothers
had the highest detection probability for glaucoma in POAG and OH. There was no significant
relation between stage of VFL and FHG in POAG (P ¼ 0.6). Sixty-eight percent of patients
would participate in genetic glaucoma tests.
CONCLUSIONS. There is a similarly high genetic disposition in all types of glaucoma. Disease risk
was especially high in mothers and siblings. In patients with FHG, knowledge of genetic
disposition of the glaucomas may have led to earlier diagnosis. This highlights the need for
glaucoma awareness campaigns.
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Glaucoma is a multifactorial condition characterized by aprogressive optic neuropathy and distinctive visual field
loss (VFL). Family history of glaucoma (FHG) is considered a
major risk factor for the development of glaucomatous disease,
which highlights the importance of a genetic background in
this group of diseases. So far there is no clinical study
comparing the frequency of FHG between different glaucomas
following systematic interviews of all first and second degree
relatives. The genetic background of glaucoma is highlighted by
the exponentially growing number of molecular genetic studies
in glaucoma. As in most complex diseases, the exact number of
genes involved in the different glaucomas, their individual
contribution to the pathogenesis of the disease, and their
specific ways of interference remain largely unknown so far.1,2
Several genes have been reported to be associated with
different types of glaucoma for example, for POAG, myocillin
[MYOC],3 optineurin [OPTN],4 and WDR36.5,6 However,
mutations in these genes account only for a small proportion
of less than 10% of POAG cases.7 For many candidate genes
results could not be replicated in different populations.7 Recent
genome-wide association studies (GWAS) identified several
common variants associated with POAG, including single
nucleotide polymorphisms (SNP) near the caveolin 1 and 2
genes (CAV1/CAV2) in a cohort from Iceland,8 and in
CDKN2BAS and SIX1/SIX6 regions in patients of European
ancestry.9 Another GWAS showed a significant association of
IOP and SNPs in TMCO1 and GAS7.10
For normal tension glaucoma (NTG) a robust association
was found with CDKN2BAS variants.9 For pseudoexfoliation
glaucoma (PEX) it was found that individuals with a specific
sequence variation in the LOXL1 gene have an increased risk to
develop PEX glaucoma up to 700-fold higher than individuals
without this sequence variant.11 The polymorphisms in the
LOXL1 gene are specifically associated with PEX, but not with
NTG and pigmentary glaucoma (PG).12 In addition, significant
associations between PEX and SNPs in the CLU and CNTNAP2
genes were found, suggesting that genetic variation in these
genes is an additional risk factor for PEX.13,14 Despite all new
findings about the molecular genetic basis of glaucoma, clinical
studies remain essential to provide new insights into clinical
characteristics of different glaucomas and disease risk in
relatives.
Cross-sectional studies have suggested that FHG conveys an
up to 3-fold increased risk to develop POAG.15,16 This
emphasizes that a thorough family history is crucial for
glaucoma screening as it helps to identify people at risk.
Therefore, the frequency of FHG and its significance for early
diagnosis of glaucoma were evaluated in this study with five
purposes: prospective evaluation of (1) differences in the
frequency of FHG in patients with POAG, primary angle closure
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glaucoma (PACG), ocular hypertension (OH), NTG, pigmentary
glaucoma (PG), and PEX, (2) differences in the age at diagnosis
between patients with and without FHG in these different
glaucomas, (3) the frequency of patients with POAG, NTG, and
OH, in whose relatives (split in 12 groups) glaucoma or OH
was detected or excluded. It was evaluated which group of
relatives (e.g., siblings, mothers) had the highest detection
probability of glaucoma or OH in the different glaucomas, (4)
the frequency of FHG in POAG patients with no, mild,
moderate, and severe VFL. Do patients with FHG show a more
severe visual field loss than patients without FHG? (5) The
acceptance rate of future genetic tests for glaucoma in
glaucoma patients.
METHODS
Two thousand one hundred and seventy glaucoma patients
interviewed their siblings, children, parents, and relatives of
mother and father (grandmothers, grandfathers, uncles,
aunts) by means of a detailed questionnaire17 with 16
standardized questions. This central part of the questionnaire
resulted in information on FHG in 12 groups of relatives
(siblings, children, mother, father, paternal grandmother,
paternal grandfather, paternal uncles, paternal aunts, mater-
nal grandmother, maternal grandfather, maternal uncles,
maternal aunts) for every patient. The questionnaire used
was designed for this study, as no such instrument was
available so far. It was developed by the authors and
presented to a group of international experts for discussion
at the workshop ‘‘Genetics in glaucoma.’’18 It was agreed
upon as a suitable instrument for this study by the experts.
The questionnaire was tested in a group of patients in an
inpatient setting concerning its feasibility. Patients received
instructions in a uniform way by the same glaucoma expert
on how to perform the interviews of their relatives before
using the questionnaire. Each relative was asked by the
patient whether glaucoma or OH had been diagnosed or
excluded by an ophthalmologist. Patients were instructed to
read out the questions word by word. Answer categories
were yes/no/do not know. Only yes or no answers were
included for further evaluation. Family history of glaucoma
was defined as glaucoma or OH in at least one first or second
degree relative. Patients were asked to provide information
on the total number of relatives in the 12 groups, the number
of relatives in the 12 groups in whom glaucoma or OH had
been found or excluded, and the number of relatives in
whom no information based on ophthalmological examina-
tion was available or who could not be interviewed by the
patient. Patients were also asked to provide information on
the type of glaucoma in their relatives, but due to lack of
reliable answers, this aspect was excluded from further
evaluation.
The first part of the questionnaire was always completed by
the same glaucoma specialist (EG) at the patient’s visit to the
University Eye Hospital Wuerzburg concerning the type of
glaucoma, age of the patient at diagnosis, and for both eyes
stage of VFL and maximal IOP, defined as the highest IOP ever
measured. Concerning age at diagnosis, all patients were asked
by the same glaucoma specialist (EG) at what age glaucoma
had been diagnosed. This was verified for each patient from the
medical records. If the answer was uncertain, a resident
contacted the patient’s ophthalmologist by telephone while
the patient was still in the examination room. Thus, age at
diagnosis was evaluated in a uniform way and confirmed from
multiple sources, if necessary. Many of the patients included
were under the care of the same glaucoma specialist (EG) for
more than thirty years. This also provides a high reliability of
diagnosis (e.g., in NTG).
The glaucoma specialist staged visual fields (VF) in both
eyes according to the classification of Aulhorn.19 Goldmann
perimetry and in addition, wherever feasible, computerized
threshold determining perimetry of the central VF were
performed. For staging the first available and reliable VF was
chosen in order to judge glaucomatous VFL at or close to the
time of diagnosis. Visual fields with Aulhorn stages I and II
were summarized as mild VFL, stages III and IV as moderate
VFL, stage V as severe VFL, and normal VF as no VFL. The eye
with more severe VFL was used for statistical evaluation. The
third part of the questionnaire addressed general risk factors
(e.g., migraine, Raynaud’s phenomenon, heart disease, blood
pressure) and systemic medication.
We received 2170 questionnaires suitable for evaluation. We
assessed the incidence of FHG in 1338 patients with POAG,
233 with PACG, 148 with OH, 153 with NTG, 50 with PG, and
66 with PEX. Information on age at diagnosis was provided for
1275 patients with POAG, 221 with PACG, 133 with OH, 147
with NTG, 49 with PG, and 65 with PEX. In the POAG group,
for example, 1335 patients interviewed 5312 relatives. Results
for other types of glaucoma (e.g., primary congenital glauco-
ma,20 glaucoma in patients with Rieger syndrome,21 and
glaucoma in aniridic patients22) were not included in this
evaluation due to small sample sizes and are published
separately. All patients received IOP lowering therapy. The
study adhered to the tenets of the Declaration of Helsinki and
written informed consent from participants was obtained.
For statistic evaluation v2 test, Fisher’s exact test 2-sided,
and Cochran-Armitage trend test were used. A P value less than
or equal to 0.05 was considered statistically significant.
RESULTS
Frequency of FHG in Different Types of Glaucoma
The overall frequency of FHG in different types of glaucoma is
shown in Table 1. Compared with POAG, the frequency of FHG
was not significantly different in PACG, OH, NTG, and PG. Only
in PEX the frequency of FHG was significantly lower than in
POAG (Fisher’s exact test, 2-sided P ¼ 0.001).
Age at Diagnosis in Different Types of Glaucoma
Compared With POAG
There was a significant difference in mean age at diagnosis in
different types of glaucoma compared with POAG (54.86 12.6
years) for NTG (57.2 6 13.4 years; P¼ 0.03), PG (43.8 6 13.0
years; P < 0.0001), OH (51.16 12.0 years; P¼0.001), and PEX
(65.5 6 7.9 years; P < 0.0001). No significant difference was
TABLE 1. Frequency of FHG in Patients With Different Types of
Glaucoma Compared With POAG
Type of Glaucoma
Patients Patients With FHG Fisher’s
Exact Test
(2-Sided)n n %
POAG 1335 548 41.0
PACG 233 102 43.8 P ¼ 0.4
OH 148 56 37.8 P ¼ 0.5
NTG 153 51 33.3 P ¼ 0.08
PG 50 18 36.0 P ¼ 0.6
PEX 66 14 21.2 P ¼ 0.001
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found in mean age at diagnosis between POAG and PACG (56.1
6 12.8 years; P ¼ 0.16).
Differences in the Age at Diagnosis Between
Patients With and Without FHG in Different Types
of Glaucoma
Patients with FHG compared with patients without FHG were
significantly younger at the time of diagnosis in POAG, PACG,
OH, and PG, but not in NTG and PEX (Table 2). Patients with
FHG compared with those without FHG were diagnosed 5
years earlier in POAG, 7 years earlier in PACG, 4 years earlier in
OH, and almost 13 years earlier in PG.
Frequency of Glaucoma or OH in 12 Groups of
Relatives of Patients With POAG, OH, and NTG
The frequency of patients, in whose relatives (split in 12
groups of relatives) glaucoma or OH had been detected or
excluded is shown for patients with POAG, NTG, and OH in
Table 3. Siblings and mothers showed the highest detection
probability for glaucoma or OH in POAG, as well as in OH. In
POAG, OH, and NTG female relatives tended to show a higher
frequency of glaucoma or OH than male relatives. Comparing
POAG, OH and NTG, family members belonging to the same
group of relatives (e.g., mothers) showed a similar relative
frequency of glaucoma or OH.
Frequency of FHG in Patients With POAG in
Relation to Stage of VFL
In 1313 POAG patients FHG was found in 41.2% (256 of 621)
of patients without VFL, 40.3% (166 of 412) of patients with
mild VFL, 38.5% (65 of 169) of patients with moderate VFL, and
46.9% (52 of 111) of patients with severe VFL. There was no
significant relation between stage of VFL and FHG (Cochran-
Armitage trend test, P ¼ 0.6).
Acceptance Rate of Genetic Tests
Out of 2170 glaucoma patients, 68.5% would like to have a
genetic glaucoma test, while 31.5% declined.
DISCUSSION
Family History of Glaucoma in Different Types of
Glaucoma
This is the first study performing a systematic patient-directed
survey on the frequency of FHG in all first and second degree
relatives in different types of glaucoma, complemented by
clinical data provided by the glaucoma specialist. Compared
with a population-based study,23 in which only 16.1% of
patients with POAG reported FHG, we found a considerably
higher proportion of FHG in POAG patients (41%). The
Baltimore Eye Study23 evaluated first-degree relatives only,
which might explain the lower incidence of FHG. Other
studies found a frequency of FHG similar to our study, such as
33.2% FHG for all types of glaucoma, 37.9% for POAG, and
35.5% for NTG,24 or even higher frequencies of FHG in 50% of
POAG patients and 43% of OH patients,25 or 59.5% in POAG
patients.16
The high variability of FHG may partly be explained by the
time span between diagnosis of glaucoma and the first
interview regarding FHG. In a previous prospective study
(Gramer E, IOVS 2000;41:ARVO Abstract 1482), 6031 patients
were interviewed on the day of first diagnosis of glaucoma. Of
the 4907 patients who were able to provide information on
FHG at time of diagnosis, FHG was reported by 18.8% with OH,
21.1% with POAG, 13.4% with NTG, and 16.9% of patients with
other types of glaucoma. In accordance with the present study,
these patients did not show significant differences in
frequency of FHG between OH, POAG, and NTG. This provides
evidence that the incidence of reported FHG presumably
depends on duration of the patients’ knowledge of the
diagnosis, and awareness of the role of genetic factors in
glaucoma.
The major limitation of questionnaire-based studies, in
particular concerning the topic of FHG, is that the patients’
immediate knowledge about FHG in their families is often
limited. Patients do not always have the possibility and time to
ascertain the actual status of FHG. The advantage of our
present study was that patients interviewed all their available
relatives systematically with standardized questions, and could
therefore provide more exact information on glaucoma or OH
in their relatives. This may also explain the higher frequency of
FHG in our study. We cannot exclude that the high frequency
of FHG in our study could also be due to the fact that the
questionnaire was predominantly completed and returned by
patients with FHG (ascertainment bias). However, the fact that
the first part of the questionnaire was already filled in by the
ophthalmologist at the time of the visit in the glaucoma clinic
should have encouraged patients with and without FHG
equally to complete the questionnaire. Also, some questions
concerned general risk factors, which again should have
encouraged patients with and without FHG to complete and
return the questionnaire. The high frequency of FHG in our
study could also partly be influenced by the fact that at least
some patients were referred to the University Eye Hospital
because of their FHG, and that consequently patients with FHG
might be overrepresented in this glaucoma service (again
ascertainment bias). The proportion of affected family mem-
bers found in our study is much higher than expected
according to population prevalence rates, which range from
1.2% to 5.6% depending on age and ethnic background.15,26
For the evaluation of differences in FHG between the
glaucomas, all selection biases discussed above may be
irrelevant, as they should influence the different types of
glaucoma equally. The limitations of our questionnaire are
TABLE 2. Differences in Age at Diagnosis in Different Types of Glaucoma Between Patients With and Without Family History of Glaucoma
Type of
Glaucoma
Patients
With FHG, n
Mean Age
at Diagnosis, y
Patients
Without FHG, n
Mean Age at
Diagnosis, y
Earlier Diagnosis
in Patients With FHG
Age
Difference, y P Value
POAG 533 51.6 6 12.8 741 57.1 6 11.9 Yes 5.5 0.0001
PACG 97 52.1 6 13.4 124 59.2 6 11.4 Yes 7.1 0.0001
OH 53 48.3 613.1 80 53.0 6 10.9 Yes 4.7 0.03
PG 17 35.4 6 9.3 32 48.2 6 12.6 Yes 12.8 0.0002
NTG 50 56.8 6 13.0 97 57.4 6 13.7 No 0.6 0.8
PEX 14 62.6 6 8.0 51 66.4 6 7.7 No 3.8 0.1
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presumably of minor significance as the Glaucoma Inheritance
Study in Tasmania revealed FHG in 59.5% of all patients by
direct examination of the relatives of 1700 POAG patients
during a 15-year period.16
One strength of this study is that assessment of frequency
of FHG and other risk factors was performed in different
glaucomas in a uniform way, using the same methods. This
approach allows for assessment of differences in FHG and age
at diagnosis between the glaucomas. We found no significant
differences in the frequency of FHG between different types of
glaucoma. This is surprising as molecular genetic studies
highlighted differences in genes involved, suggesting genetic
heterogeneity in different types of glaucoma.3,6,9–13,27,28 In
clinical practice, our finding signifies that for all types of
glaucoma FHG is equally important and supports the necessity
of repeated interviews on FHG in patient care. In the United
Kingdom, awareness of the significance of FHG in glaucoma
screening already led to implementation of a no cost National
Health Service (NHS) sight test for people with the risk factor
FHG.29
Age at Diagnosis in Different Types of Glaucoma
Compared with POAG, there was a significant difference in the
age at diagnosis between different types of glaucoma. Patients
with POAG, PACG, OH, and PG with FHG were significantly
younger at the time of diagnosis compared with patients
without FHG. In PG, a predominantly binocular disease with
early onset and high genetic predisposition,30 patients with
FHG were diagnosed almost 13 years earlier than those
without. We suggest that awareness of FHG, and perhaps a
deeper knowledge of the disease, may have led to earlier
presentation at the ophthalmologist. In accordance with our
results, Landers et al.1 found in a study on POAG, that patients
with FHG were younger at diagnosis than those without.
Our result that PEX patients with FHG were not signifi-
cantly younger at diagnosis than those without FHG could be
due to the fact that PEX patients are mostly older at disease
onset than those with other glaucomas.17 At disease onset
their relatives might already have passed away, and therefore
cannot provide information on glaucoma and raise awareness
of the disease, what could have resulted in earlier consultation
of an ophthalmologist and might have led to earlier diagnosis.
We suggest that the lack of earlier diagnosis in NTG patients
with FHG could be explained by the fact that NTG was more
frequently diagnosed at a later stage of the disease than IOP-
dependant glaucomas, also detectable by IOP screening.17 In
addition, the differences in mean age at diagnosis suggest
differences in the onset of the disease in the glaucomas.
Knowledge of these differences is important for an effective
glaucoma screening.
Disease Risk in Relatives in Different Types of
Glaucoma
Siblings and mothers showed the highest detection probability
for glaucoma and OH. Female family members tended to show
a higher frequency of glaucoma or OH than males. In the
children of POAG patients no sex difference was found,17 but
in siblings sisters were more often affected than brothers.17 In
the Barbados Epidemiological Study one-fifth of 338 siblings of
open angle glaucoma (OAG) patients had OAG, but these were
more often male.31 Overall, approximately one-fourth of the
relatives had OAG or were glaucoma suspects. This was found
in a population with African heritage, which is also known to
be a significant risk factor for OAG. Individuals of African
descent generally have a higher prevalence of OAG and tend to
develop it at an earlier age.32 We suggest that the higherT
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frequency of affected sisters in our study may be in part due to
an age-related effect and not a sex-related difference. Females
have a higher life expectancy and therefore have a higher risk
to develop age-related diseases. Whether this age effect fully
explains why mothers compared with fathers, and grandmoth-
ers compared with grandfathers had a higher frequency of
glaucoma or OH is unknown. The age of the relatives was not
asked in the questionnaire. In addition, cultural or social
factors may be of relevance.
A study on NTG found an association of SNPs in the genes
for Mitofusin 1 and 2, suggesting an involvement of mitochon-
drial inheritance in NTG.33 A further study showed that people
with haplogroup U have a lower risk to develop exfoliation
glaucoma.34 These results suggested that mitochondrial
alterations may be involved in the etiology of glaucoma.
However, like for many other glaucoma genes, the association
of Mitofusin 1 and 2 and NTG has so far not been replicated in
other studies. Former studies also showed that in NTG a
maternal history of glaucoma is more prevalent than a paternal
history.35–37 This more pronounced maternal inheritance could
support the involvement of mitochondrial dysfunction in
glaucoma.
Stage of Visual Field Loss in Relation to FHG in
POAG
In our study, POAG patients with severe VFL did not show a
significantly higher frequency of FHG than patients with no,
mild, or moderate VFL. This is a comforting result for patients
with FHG, who are often concerned about a presumably higher
risk of blindness due to their FHG. From our data, we did not
find evidence for an increased risk to develop a more severe
VFL in patients with FHG, given timely diagnosis and
appropriate treatment. Also in other studies, we did not find
a significant relation between stage of VFL and FHG in patients
with NTG (Gramer E, IOVS 2006;47:ARVO E-Abstract 3395)
and in patients with PG.30 Wu et al.16 found, based on a
different definition of the stage of the disease than the studies
mentioned above, a significant difference in severity of familial
glaucoma compared with sporadic glaucoma.
CONCLUSIONS
Our study highlights that glaucoma screening in relatives of
glaucoma patients based on clinical examination is very
effective in siblings, more effective in females than males,
and significant in all types of glaucoma for early detection of
the different types of glaucoma. Therefore, awareness cam-
paigns informing the population about the role of genetic
factors in the glaucomas are important in order to provide
screening examinations for all individuals with FHG. The
potential future of genetic testing in glaucoma, which was
shown in our study to have a high acceptance rate in glaucoma
patients, may hopefully allow to genetically identify family
members with or at risk for the disease. This would allow to
focus glaucoma screening even more effectively in this high-
risk group. Family history of glaucoma is a fate, because
relatives have an increased risk to develop the same disease,
but it also offers the chance for early diagnosis, early treatment,
and thus a better prognosis concerning the prevention of
irreversible blindness.
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